The impact of histologic grade on the outcome of high-dose therapy and autologous stem cell transplantation for follicular lymphoma

Bone Marrow Transplantation

Volumn 40, Issue 11, 2007, Pages 1039-1044

  Pham, R N ^a   Gooley, T A ^b   Keeney, G E ^a   Press, O W ^a,b   Pagel, J M ^a,b   Greisman, H A ^a   Bensinger, W I ^a,b   Holmberg, L A ^a,b   Petersdorf, S H ^a,b   Maloney, D G ^a,b   Gopal, A K ^a,b  

^a UNIVERSITY OF WASHINGTON   (United States)

^b USA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTHRACYCLINE; B LYMPHOCYTE ANTIBODY; BUSULFAN; CARMUSTINE; CYCLOPHOSPHAMIDE; CYTARABINE; ETOPOSIDE; LACTATE DEHYDROGENASE; MELPHALAN; RITUXIMAB;

ADULT; AGED; ARTICLE; AUTOLOGOUS STEM CELL TRANSPLANTATION; CANCER CHEMOTHERAPY; CANCER GRADING; CANCER MORTALITY; CANCER RELAPSE; COHORT ANALYSIS; COMBINATION CHEMOTHERAPY; DISEASE FREE SURVIVAL; DRUG MEGADOSE; FEMALE; FOLLICULAR LYMPHOMA; FOLLOW UP; HAZARD RATIO; HISTOPATHOLOGY; HUMAN; LACTATE DEHYDROGENASE BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; MONOTHERAPY; OUTCOMES RESEARCH; OVERALL SURVIVAL; PREDICTION; PRIORITY JOURNAL; RADIATION EXPOSURE; RADIOIMMUNOTHERAPY; RISK FACTOR; WHOLE BODY RADIATION;

ADULT; AGED; ANTINEOPLASTIC AGENTS; COHORT STUDIES; COMBINED MODALITY THERAPY; DISEASE PROGRESSION; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; KAPLAN-MEIERS ESTIMATE; LYMPHOMA, FOLLICULAR; MALE; MIDDLE AGED; PROGNOSIS; RADIOTHERAPY, ADJUVANT; RETROSPECTIVE STUDIES; TRANSPLANTATION CONDITIONING; TRANSPLANTATION, AUTOLOGOUS;

EID: 36348986077     PISSN: 02683369     EISSN: 14765365     Source Type: Journal    
DOI: 10.1038/sj.bmt.1705864     Document Type: Article

References (30)

1. Jemal A, Murray T, Ward E, Samuels A, Tiwari RC, Ghafoor A et al. Cancer statistics, 2005. CA Cancer J Clin 2005; 55: 10-30.
2. Fisher SG, Fisher RI. The epidemiology of non-Hodgkin's lymphoma. Oncogene 2004; 23: 6524-6534.
3. Armitage JO, Weisenburger DD. New approach to classifying non-Hodgkin's lymphomas: Clinical features of the major histologic subtypes. Non-Hodgkin's Lymphoma Classification Project. J Clin Oncol 1998; 16: 2780-2795.
4. Nathwani B, Harris N, Weisenburger D, Isaacson P, Piris MA, Berger F et al. Follicular lymphoma. In: Jaffe E, Harris N, Stein H, Vardiman J (eds). Pathology and Genetics of Tumours of Haematopoietic and Lymphoid Tissues. IARC Press: Lyons, France, 2001, pp 162-167.
5. National Cancer Institute sponsored study of classifications of non-Hodgkin's lymphomas: Summary and description of a working formulation for clinical usage. The Non-Hodgkin's Lymphoma Pathologic Classification Project. Cancer 1982; 49: 2112-2135.
6. Stansfeld AG, Diebold J, Noel H, Kapanci Y, Rilke F, Kelenyi G et al. Updated Kiel classification for lymphomas. Lancet 1988; 1 292 293.
7. Bartlett NL, Rizeq M, Dorfman RF, Halpern J, Horning SJ. Follicular large-cell lymphoma: Intermediate or low grade? J Clin Oncol 1994; 12: 1349-1357.
8. Longo DL. What's the deal with follicular lymphomas? J Clin Oncol 1993; 11: 202-208.
9. Wendum D, Sebban C, Gaulard P, Coiffier B, Tilly H, Cazals D et al. Follicular large-cell lymphoma treated with intensive chemotherapy: an analysis of 89 cases included in the LNH87 trial and comparison with the outcome of diffuse large B-cell lymphoma. Groupe d'Etude des Lymphomes de l'Adulte. J Clin Oncol 1997; 15: 1654-1663.
10. Rodriguez J, McLaughlin P, Hagemeister FB, Fayad L, Rodriguez MA, Santiago M et al. Follicular large cell lymphoma: An aggressive lymphoma that often presents with favorable prognostic features. Blood 1999; 93: 2202-2207.
11. Anderson JR, Vose JM, Bierman PJ, Weisenberger DD, Sanger WG, Pierson J et al. Clinical features and prognosis of follicular large-cell lymphoma: A report from the Nebraska Lymphoma Study Group. J Clin Oncol 1993; 11: 218-224.
12. Horning SJ, Weiss LM, Nevitt JB, Warnke RA. Clinical and pathologic features of follicular large cell (nodular histiocytic) lymphoma. Cancer 1987; 59: 1470-1474.
13. Miller TP, LeBlanc M, Grogan TM, Fisher RI. Follicular lymphomas: Do histologic subtypes predict outcome? Hematol Oncol Clin North Am 1997; 11: 893-900.
14. Schouten HC, Qian W, Kvaloy S, Porcellini A, Hagberg H, Johnson HE et al. High-dose therapy improves progression-free survival and survival in relapsed follicular non-Hodgkin's lymphoma: Results from the randomized European CUP trial. J Clin Oncol 2003; 21: 3918-3927.
15. Apostolidis J, Gupta RK, Grenzelias D, Johnson PW, Pappa VI, Summers KE et al. High-dose therapy with autologous bone marrow support as consolidation of remission in follicular lymphoma: Long-term clinical and molecular follow-up. J Clin Oncol 2000; 18: 527.
16. Freedman AS, Neuberg D, Mauch P, Soiffer RJ, Anderson KC, Fisher DC et al. Long-term follow-up of autologous bone marrow transplantation in patients with relapsed follicular lymphoma. Blood 1999; 94 3325-3333.
17. Gopal AK, Gooley TA, Maloney DG, Petersdorf SH, Eary JF, Rajendran JG et al. High-dose radioimmunotherapy versus conventional high-dose therapy and autologous hematopoictic stem cell transplantation for relapsed follicular non-Hodgkin lymphoma: A multivariable cohort analysis. Blood 2003; 102: 2351-2357.
18. Vose JM, Zhang MJ, Rowlings PA, Lazarus HM, Bolwell BJ, Freytes CO et al. Autologous transplantation for diffuse aggressive non-Hodgkin's lymphoma in patients never achieving remission: A report from the Autologous Blood and Marrow Transplant Registry. J Clin Oncol 2001; 19: 406-413.
19. Stiff PJ, Dahlberg S, Forman SJ, McCall AR, Horning SJ, Nademanee AP et al. Autologous bone marrow transplantation for patients with relapsed or refractory diffuse aggressive non-Hodgkin's lymphoma: Value of augmented preparative regimens - a Southwest Oncology Group trial. J Clin Oncol 1998; 16: 48-55.
20. Philip T, Guglielmi C, Hagenbeek A, Somers R, Van der Lelie H, Bron D et al. Autologous bone marrow transplantation as compared with salvage chemotherapy in relapses of chemotherapy-sensitive non-Hodgkin's lymphoma [see comments]. N Engl J Med 1995; 333: 1540-1545.
21. Cheson BD, Horning SJ, Coiffier B, Shipp MA, Fisher RI, Connors JM et al. Report of an international workshop to standardize response criteria for Non-Hodgkin's Lymphomas. J Clin Oncol 1999; 17: 1244-1253.
22. Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc 1958; 53: 457-481.
23. Press OW, Eary JF, Appelbaum FR, Martin PJ, Badger CC, Nelp WB et al. Radiolabeled-antibody therapy of B-cell lymphoma with autologous bone marrow support. N Engl J Med 1993; 329: 1219-1224.
24. Krishnan A, Nademanee A, Fung H, Angelopoulou M, Molina A, Gaal K et al. Does follicularity in large cell lymphoma predict outcome after autologous stem cell transplantation? Biol Blood Marrow Transplant 2006; 12: 641-647.
25. Vose JM, Bierman PJ, Lynch JC, Weisenburger DD, Kessinger A, Chan WC et al. Effect of follicularity on autologous transplantation for large-cell non-Hodgkin's lymphoma. J Clin Oncol 1998; 16: 844-849.
26. Ott G, Katzenberger T, Lohr A, Kindelberger S, Rudiger T, Wilhelm M et al. Cytomorphologic, immunochistochemical, and cytogenetic profiles of follicular lymphoma: 2 types of follicular lymphoma grade 3. Blood 2002; 99: 3806-3812.
27. Hans CP, Weisenburger DD, Vose JM, Hock LM, Lynch JC, Aoun P et al. A significant diffuse component predicts for inferior survival in grade 3 follicular lymphoma, but cytologic subtypes do not predict survival. Blood 2003; 101: 2363-2367.
28. Wang SA, Wang L, Hochberg EP, Muzikansky A, Harris NL, Hasserjian RP. Low histologic grade follicular lymphoma with high proliferation index: morphologic and clinical features. Am J Surg Pathol 2005; 29 1490-1496.
29. Husson H, Carideo EG, Neuberg D, Schultze J, Munoz O, Marks PW et al. Gene expression profiling of follicular lymphoma and normal germinal center B cells using cDNA arrays. Blood 2002; 99: 282-289.
30. Dave SS, Wright G, Tan B, Rosenwald A, Gascoyne RD, Chan WC et al. Prediction of survival in follicular lymphoma based on molecular features of tumor-infiltrating immune cells. N Engl J Med 2004; 351: 2159-2169.